A next-generation, anti-CD19 enhanced (or "armored") CAR T-cell product showed promising efficacy and safety in a phase I ...

The White House is withdrawing the nomination of a former Fox News medical contributor Janette Nesheiwat, MD, for U.S.

The partnership will focus first on "enabling research around the root causes" of autism spectrum disorder (ASD), HHS said.

A prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...

House Republicans appear to be backing off some, but not all, of the steep reductions to the Medicaid program as part of ...

Obicetrapib provided dramatic reductions in LDL cholesterol, without noticeable side effects, in a phase III trial of ...

Rocha-Cabrero is an adult board-certified general neurologist and clinical neurophysiologist.

A meta-analysis of 1,683 randomized clinical trials found an underrepresentation of certain racial and ethnic groups ...

Adding tumor-bed biopsy to trimodality imaging after neoadjuvant chemotherapy did not reliably predict pathological complete ...

Now that HHS Secretary Robert F. Kennedy Jr. oversees the vaccine database he said holds the answer to the cause of autism, ...